Related Experiment Video
Updated: May 14, 2026
04:23
A Swin Transformer-Based Model for Thyroid Nodule Detection in Ultrasound Images
Published on: April 21, 2023
Can a gene-expression classifier with high negative predictive value solve the indeterminate thyroid fine-needle
1Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. wfaquin@partners.org
Cancer Cytopathology
|February 1, 2013
Summary
The Afirma test effectively evaluates indeterminate thyroid nodules. This study suggests it can be a valuable supplementary tool for physicians diagnosing thyroid conditions.
Area of Science:
- Endocrinology
- Oncology
- Molecular Diagnostics
Background:
- Thyroid nodules are common, with a subset classified as indeterminate by fine-needle aspiration (FNA).
- Accurate diagnosis of indeterminate thyroid nodules is crucial to differentiate benign from malignant cases and guide management.
- Current diagnostic pathways for indeterminate thyroid nodules can be challenging, necessitating improved tools.
Purpose of the Study:
- To validate the effectiveness of the Afirma test in the diagnostic workup of thyroid nodules.
- To explore the ancillary role of the Afirma test in managing indeterminate thyroid nodules.
Main Methods:
- The study by Alexander et al. evaluated the performance of the Afirma test.
- Analysis focused on cases where fine-needle aspiration yielded indeterminate results.
- The Afirma test's diagnostic accuracy and clinical utility were assessed.
Main Results:
- The Afirma test demonstrated effectiveness in the evaluation of thyroid nodules.
- The study confirmed the test's utility when applied to indeterminate thyroid nodule classifications.
Conclusions:
- The Afirma test is a validated tool for assessing thyroid nodules.
- The findings support an ancillary role for the Afirma test in the clinical management of indeterminate thyroid nodules.
